Curie.Bio
Curie.Bio is a seed-stage biotech venture firm and drug-discovery co-pilot co-founded by Zach Weinberg (founder of Flatiron Health), Alexis Borisy, and Christoph Lengauer. It pairs seed investment — typically $5M-$7M initial checks, backed by a $380M pro-rata Series A follow-on fund — with hands-on scientific and operational support from a team of experienced drug hunters, helping therapeutics founders design their science and move programs into the clinic and toward a strong next round of financing. Curie.Bio has raised close to $1B and is backed by GV, a16z, and ARCH Venture Partners. It operates as a company/investor profile in the API Evangelist network; it publishes no public developer API or platform, so most technical API artifacts are not applicable to this provider.
Curie.Bio is profiled on the APIs.io network. Tagged areas include Company, Venture Capital, Biotechnology, Life Sciences, and Drug Discovery.
Curie.Bio’s developer surface includes support and 8 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Documentation 1
Reference material describing how the API behaves
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 4
The organization behind the API